CinCor Pharma, Inc. Common Stock (CINC)

CINC was delisted on the 23rd of February, 2023.

• Market cap: $1.27B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: CinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.

Employees: 19